ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 283440 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 283440; 2) Community: the network communities that were significantly associated with the response to NSC 283440; 3) Molecule: the relationships between components within communities and NSC 283440; 4) MDR: the compounds that were significantly associated with the NSC 283440.

NSC Compound Enrichment Correlation
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0474314077111082 0.26257598
NSC 750762 2-methoxy-7-benzyl-3-(phenylsulfonyl)-6,7-dihydro-5H-pyrazolo[3,4-h]quinoline 0.0474314077111082 0.13322896
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0474314077111082 0.26025233
NSC 756173 GSK326090A 0.0474314077111082 0.18320932
NSC 758706 Simvastatin (USAN) 0.0474314077111082 -0.17655544
NSC 763232 Null 0.0474314077111082 0.27624375
NSC 83066 8-Quinolinol, 5-(chloromethyl)-, hydrochloride 0.0474314077111082 0.29211886
NSC 85235 10.alpha.H-Ambrosa-2,11(13)-dien-12-oic acid, 6.beta.-hydroxy-4-oxo-, .gamma.-lactone (8CI) 0.0474314077111082 0.60877424
NSC 87500 Solacongestidine 0.0474314077111082 0.20627418
NSC 289074 Null 0.0480633950058471 0.56620647
Total:90  Current:83    [First] [Prev] [Next] [Last]